BPA Call HSCECR12A00007-HSCECR13J00008

This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...

The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...

Research Triangle Institute (RTI) International was awarded a $707,813 time and materials contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide cost effectiveness analysis services for the Tuberculosis Epidemiologic Studies Consortium III (TBESC-III). The contract calls for RTI to design and implement cost effectiveness analyses of clinical interventions to improve performance across the latent tuberculosis infection care cascade. RTI...

Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...

This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...

This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County, for tuberculosis trials and consortium services. The $10,667,136.30 contract has an ultimate completion date of December 31, 2030. It does not have a set-aside designation, indicating it was competed on a full and open basis. The contract will support clinical trials and research on the treatment, diagnosis, and prevention of...

This is a $64,801,397 task order awarded by USAID to University Research Co., LLC under the Technical Assistance Support Contract 4 (TASC 4) IDIQ for a 5-year project to implement a tuberculosis control program in South Africa. The project aims to reduce the burden of TB in South Africa through community-based interventions, including TB awareness, screening, contact tracing, and treatment support. The contract does not have a set-aside designation. The prime contractor, University Research Co.,...

This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Siris Pharmaceutical Services LLC, a woman-owned small business, to provide tuberculosis (TB) clinical trials management support. The contract has a ceiling value of $2,395,614.70 and is a time and materials contract with a period of performance ending on September 10, 2026. The contract is designated as a total small business set-aside. This contract supports the CDC's efforts to advance TB research...

This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Hawaii Department of Health - Children With Special Health Needs - NBS Division, a state government entity, to conduct a comparison of tuberculosis skin tests (TST) versus interferon-gamma release assays (IGRA) in patients with latent tuberculosis infection (LTBI). The $3,733,229.06 cost-no-fee contract has an ultimate completion date of September 29, 2021 and is a delivery order under the...

This is a $5,176,985.37 cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County. The contract is to develop, implement, and evaluate interventions to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The contract is part of the TBESC 3 - Seattle and King County program and does not have a...